Showing results (121-130 of 463) with videos related to
Sort By:
Pageof 47
Surgical Endoscopy|April 19, 2002
Selection criteria among gastroenterologists and surgeons for laparoscopic antireflux surgeryB Sarani, J Scanlon, P Jackson, et al.Carcinogenesis|September 1, 1994
Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacityP Taverna, J Hansson, K J Scanlon, et al.The Journal of Investigative Dermatology|February 1, 1996
Suppression of the malignant phenotype of melanoma cells by anti-oncogene ribozymesY Ohta, H Kijima, M Kashani-Sabet, et al.The Biochemical Journal|June 26, 2025
Methods to accelerate PROTAC drug discoveryJeyan Osman, Philip E Thompson, Manuela Jörg, et al.Journal of Neurosurgical Anesthesiology|September 25, 2008
N-methyl-D-aspartate (NMDA) antagonists--S(+)-ketamine, dextrorphan, and dextromethorphan--act as calcium antagonists on bovine cerebral arteriesIhab R Kamel, Woodrow W Wendling, Dong Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cellsK J Scanlon, E M Newman, Y Lu, et al.Gene Therapy|February 15, 2001
Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude miceY A Zhang, J Nemunaitis, K J Scanlon, et al.Molecules (Basel, Switzerland)|July 21, 2016
Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence AgentsRoxanne P Smith, Jason J Paxman, Martin J Scanlon, et al.Circulation|August 1, 1990
Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular functionD J Wilber, B Olshansky, J F Moran, et al.In Vivo (Athens, Greece)|May 1, 1997
Reversal of cisplatin resistance in vivo by an anti-fos ribozymeT Funato, T Ishii, M Kanbe, et al.Pageof 47